On ECHEMI
Home > Drugs > Congenital hepatic fibrosis
Congenital hepatic fibrosis
Congenital hepatic fibrosis is a rare hereditary congenital malformation characterized by hyperplasia of connective tissue in the portal area and hyperplasia of small bile ducts. In the later stages of the disease, it usually leads to portal hypertension, and 50% of patients may die from massive gastrointestinal bleeding. Kerr et al. (1961) first named this disease congenital hepatic fibrosis.
  • Site of disease:

    Liver blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Blood in stool fever stomach ache intrahepatic bile duct stones hepatosplenomegaly
  • Concurrent disease:

Related Drugs
Sophora flavescens tablets
Indication: Used for the treatment of chronic hepatitis B and the improvement of serological indicators of liver fibrosis in viral hepatitis [hyaluronic acid (HA) and type III procollagen (PⅢP)].
Manufacturer:

Shandong Qidu Pharmaceutical Co., Ltd.

Gansukang Capsules
Manufacturer:

Harbin Songhe Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.